Skip to content

Diabetes and Cataract Surgery

Progression of Diabetic Retinopathy following uncomplicated phaco-emulsification, a prospective study.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012799
Enrollment
330
Registered
2018-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients with established or no diabetic retinopathy in a known case of diabetes mellitus undergoing cataract surgery by phacoemulsification in one eye, with no intraoperative complications are included and the fellow eye which is not operated will sever as a control

Exclusion criteria

Exclusion criteria: Patients with co-existing other retinal pathology, previous intraocular surgeries or inflammation, complications during phacoemulsification procedure.

Design outcomes

Primary

MeasureTime frame
Progression of diabetic retinopathy in uncompliocated phacoemulsification.Timepoint: 18 months

Secondary

MeasureTime frame
Determine post-operative visual acuity based on the review status.Timepoint: 18 months from the date of enrolment.

Countries

India

Contacts

Public ContactDr S J Saikumar

Giridhar Eye Institute

sruthiramakrishnan007@gmail.com9746009542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026